Q-omics provides the consensus-scored ADAMTS7P1 profile across patient tissues and cancer cell-line models. ADAMTS7P1 expression is associated with patient survival in 20 of 34 cancer types, with the highest sampling consensus in UCS. Among the 18 cancer types available for tumor–normal comparison, ADAMTS7P1 is differentially expressed in 9, with the highest sampling consensus in KIRC. Additionally, ADAMTS7P1 RNA expression shows 15,144 significant gene co-expression associations, with the highest sampling consensus in KIRP. Together, these results highlight UCS, KIRC, and KIRP as cancer lineages where ADAMTS7P1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for ADAMTS7P1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes ADAMTS7P1 survival associations across molecular data types. ADAMTS7P1 RNA expression shows survival associations in the most cancer types (20), followed by mutation status (2). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible ADAMTS7P1 RNA expression–survival associations across cancer types. High ADAMTS7P1 expression shows unfavorable associations in MESO, LGG and ESCA, but favorable associations in UCS, PAAD and BLCA. The UCS Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify UCS as the clearest survival context for ADAMTS7P1 RNA expression.
This table summarizes ADAMTS7P1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 9. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for ADAMTS7P1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. ADAMTS7P1 shows lower tumor expression in LUSC and LUAD and higher tumor expression in KIRC, HNSC, BRCA and LIHC. The KIRC box plot shows higher ADAMTS7P1 RNA expression in tumor versus normal tissue (log2 FC = +0.104, t-test p < 0.001).
This table shows molecular features associated with ADAMTS7P1 in patient tissues and cancer cell lines. In patient samples, ADAMTS7P1 shows the broadest associations at the RNA and protein expression levels, with KIRP recurring as the lineage with the largest associated feature set.
